| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 10 | 2018 | 1891 | 1.040 |
Why?
|
| Regeneration | 4 | 2020 | 1537 | 0.960 |
Why?
|
| Muscle, Skeletal | 9 | 2021 | 4902 | 0.940 |
Why?
|
| Muscle Development | 6 | 2020 | 299 | 0.900 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 44 | 0.890 |
Why?
|
| Mammaplasty | 5 | 2017 | 1074 | 0.850 |
Why?
|
| Skin Transplantation | 5 | 2018 | 1259 | 0.820 |
Why?
|
| Mastectomy | 3 | 2017 | 1634 | 0.820 |
Why?
|
| Surgical Wound Infection | 3 | 2018 | 1399 | 0.820 |
Why?
|
| Guided Tissue Regeneration | 1 | 2019 | 96 | 0.790 |
Why?
|
| Aortic Aneurysm, Abdominal | 8 | 2006 | 1130 | 0.780 |
Why?
|
| Occlusive Dressings | 1 | 2018 | 58 | 0.760 |
Why?
|
| Quadriceps Muscle | 1 | 2019 | 121 | 0.750 |
Why?
|
| Tissue Scaffolds | 3 | 2021 | 928 | 0.710 |
Why?
|
| Breast Implantation | 2 | 2017 | 205 | 0.700 |
Why?
|
| Chitosan | 1 | 2018 | 131 | 0.690 |
Why?
|
| Surgical Flaps | 6 | 2018 | 1608 | 0.670 |
Why?
|
| Contracture | 2 | 2016 | 196 | 0.640 |
Why?
|
| Matrix Metalloproteinase 9 | 7 | 2006 | 713 | 0.640 |
Why?
|
| Matrix Metalloproteinase 2 | 4 | 2006 | 479 | 0.590 |
Why?
|
| Parabiosis | 1 | 2014 | 69 | 0.570 |
Why?
|
| Wound Healing | 5 | 2021 | 2791 | 0.570 |
Why?
|
| Facial Transplantation | 4 | 2021 | 224 | 0.550 |
Why?
|
| Muscular Diseases | 1 | 2017 | 543 | 0.510 |
Why?
|
| Pancreatic Elastase | 6 | 2006 | 140 | 0.500 |
Why?
|
| Fibrosis | 3 | 2018 | 1734 | 0.490 |
Why?
|
| Cartoons as Topic | 1 | 2011 | 17 | 0.480 |
Why?
|
| Osteosarcoma | 1 | 2016 | 898 | 0.420 |
Why?
|
| Recovery of Function | 2 | 2019 | 2879 | 0.390 |
Why?
|
| Cell Cycle | 1 | 2016 | 3051 | 0.340 |
Why?
|
| Muscle Fibers, Skeletal | 5 | 2018 | 557 | 0.330 |
Why?
|
| Child Welfare | 1 | 2011 | 568 | 0.330 |
Why?
|
| Breast | 1 | 2015 | 1674 | 0.320 |
Why?
|
| Nitroso Compounds | 1 | 2006 | 69 | 0.320 |
Why?
|
| Facial Injuries | 2 | 2017 | 177 | 0.310 |
Why?
|
| Nitric Oxide Donors | 1 | 2006 | 127 | 0.310 |
Why?
|
| Testosterone | 2 | 2014 | 2276 | 0.310 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9445 | 0.300 |
Why?
|
| Muscle Strength | 2 | 2019 | 562 | 0.280 |
Why?
|
| Health Education | 1 | 2011 | 1040 | 0.280 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 617 | 0.270 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2006 | 1297 | 0.270 |
Why?
|
| Adipose Tissue | 1 | 2016 | 3126 | 0.270 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 2516 | 0.260 |
Why?
|
| Surgery, Plastic | 3 | 2016 | 539 | 0.250 |
Why?
|
| Cell Proliferation | 2 | 2017 | 10811 | 0.250 |
Why?
|
| Cell Movement | 4 | 2018 | 5686 | 0.250 |
Why?
|
| Organ Size | 3 | 2019 | 2328 | 0.250 |
Why?
|
| Aging | 3 | 2020 | 8050 | 0.250 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 435 | 0.240 |
Why?
|
| India | 5 | 2016 | 2129 | 0.240 |
Why?
|
| Animals | 30 | 2021 | 168501 | 0.210 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2006 | 596 | 0.210 |
Why?
|
| Wounds and Injuries | 3 | 2021 | 2406 | 0.200 |
Why?
|
| Skin Pigmentation | 1 | 2021 | 269 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2006 | 8745 | 0.190 |
Why?
|
| Tissue Engineering | 2 | 2021 | 1850 | 0.190 |
Why?
|
| Health Promotion | 1 | 2011 | 2125 | 0.190 |
Why?
|
| Ischemic Preconditioning | 1 | 2018 | 89 | 0.190 |
Why?
|
| Leukocytes | 1 | 2006 | 2091 | 0.180 |
Why?
|
| Replantation | 1 | 2018 | 168 | 0.170 |
Why?
|
| Glycosaminoglycans | 1 | 2019 | 591 | 0.170 |
Why?
|
| Fetus | 2 | 2014 | 1700 | 0.170 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2016 | 11 | 0.160 |
Why?
|
| Organ Preservation | 1 | 2018 | 258 | 0.160 |
Why?
|
| Pentylenetetrazole | 1 | 2016 | 60 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2006 | 2356 | 0.160 |
Why?
|
| Rats | 10 | 2018 | 25424 | 0.160 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 18853 | 0.160 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2016 | 62 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 22892 | 0.160 |
Why?
|
| Mice | 15 | 2021 | 79108 | 0.160 |
Why?
|
| Keratinocytes | 2 | 2018 | 822 | 0.160 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 124 | 0.160 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 285 | 0.160 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 275 | 0.150 |
Why?
|
| Transplantation, Homologous | 4 | 2021 | 4809 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3150 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2021 | 3466 | 0.150 |
Why?
|
| Hypertrophy | 2 | 2014 | 560 | 0.140 |
Why?
|
| Breast Implants | 1 | 2017 | 350 | 0.140 |
Why?
|
| Transplantation, Autologous | 2 | 2018 | 2024 | 0.140 |
Why?
|
| Aorta, Abdominal | 3 | 2006 | 710 | 0.140 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 18133 | 0.140 |
Why?
|
| Graft Survival | 4 | 2018 | 3679 | 0.140 |
Why?
|
| Wrist Injuries | 1 | 2015 | 192 | 0.130 |
Why?
|
| Time Factors | 6 | 2018 | 41842 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 2015 | 464 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2016 | 375 | 0.130 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 502 | 0.130 |
Why?
|
| Neutrophil Infiltration | 2 | 2006 | 428 | 0.130 |
Why?
|
| Kerosene | 1 | 2012 | 16 | 0.130 |
Why?
|
| Hand Injuries | 1 | 2015 | 243 | 0.130 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 871 | 0.120 |
Why?
|
| Graft Rejection | 3 | 2021 | 4211 | 0.120 |
Why?
|
| Extremities | 1 | 2018 | 862 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2016 | 528 | 0.120 |
Why?
|
| West Virginia | 1 | 2011 | 26 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2017 | 697 | 0.120 |
Why?
|
| Mitochondria | 1 | 2005 | 3455 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1401 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 12483 | 0.120 |
Why?
|
| Thoracic Wall | 1 | 2013 | 195 | 0.120 |
Why?
|
| Cytokines | 1 | 2006 | 7006 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2009 | 3946 | 0.110 |
Why?
|
| Perfusion | 3 | 2018 | 1249 | 0.110 |
Why?
|
| Cells, Cultured | 9 | 2018 | 20583 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2018 | 1557 | 0.110 |
Why?
|
| Hypothyroidism | 1 | 2016 | 624 | 0.110 |
Why?
|
| Male | 23 | 2021 | 343917 | 0.110 |
Why?
|
| Humans | 36 | 2021 | 660731 | 0.110 |
Why?
|
| Collagen | 1 | 2019 | 2727 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2016 | 1124 | 0.110 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 102 | 0.110 |
Why?
|
| Stem Cells | 2 | 2014 | 3529 | 0.100 |
Why?
|
| Irritants | 1 | 2009 | 46 | 0.100 |
Why?
|
| Workload | 1 | 2016 | 824 | 0.100 |
Why?
|
| Osteogenesis | 2 | 2014 | 1234 | 0.100 |
Why?
|
| Female | 22 | 2021 | 365199 | 0.100 |
Why?
|
| Apoptosis | 2 | 2009 | 10232 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2510 | 0.100 |
Why?
|
| Dioxoles | 1 | 2009 | 114 | 0.100 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2009 | 100 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2018 | 3081 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2018 | 4296 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2014 | 754 | 0.100 |
Why?
|
| Myostatin | 1 | 2009 | 114 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 2004 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2017 | 1049 | 0.100 |
Why?
|
| Skin Ulcer | 1 | 2009 | 129 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2016 | 1109 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2006 | 1651 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2018 | 7624 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 1411 | 0.090 |
Why?
|
| Cell Line | 2 | 2020 | 16952 | 0.090 |
Why?
|
| Earthquakes | 1 | 2010 | 179 | 0.090 |
Why?
|
| Soft Tissue Injuries | 1 | 2009 | 179 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2020 | 40276 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 1560 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2016 | 2544 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 486 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1550 | 0.090 |
Why?
|
| Reading | 1 | 2011 | 521 | 0.090 |
Why?
|
| Patient Preference | 1 | 2015 | 843 | 0.090 |
Why?
|
| Cyclic N-Oxides | 1 | 2006 | 74 | 0.090 |
Why?
|
| Treatment Outcome | 8 | 2018 | 59149 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2020 | 23844 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 859 | 0.080 |
Why?
|
| Sarcopenia | 1 | 2009 | 234 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2020 | 11593 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2014 | 12057 | 0.080 |
Why?
|
| International Cooperation | 2 | 2011 | 1523 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 1628 | 0.080 |
Why?
|
| Burn Units | 2 | 2017 | 145 | 0.080 |
Why?
|
| Leiomyosarcoma | 1 | 2009 | 434 | 0.080 |
Why?
|
| Reconstructive Surgical Procedures | 3 | 2015 | 1997 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1771 | 0.080 |
Why?
|
| Caspase 9 | 1 | 2005 | 211 | 0.080 |
Why?
|
| Spin Labels | 1 | 2006 | 309 | 0.080 |
Why?
|
| African Americans | 1 | 2021 | 4975 | 0.070 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2004 | 18 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2016 | 2841 | 0.070 |
Why?
|
| Disasters | 1 | 2010 | 506 | 0.070 |
Why?
|
| Catalase | 1 | 2005 | 247 | 0.070 |
Why?
|
| Developing Countries | 3 | 2012 | 2699 | 0.070 |
Why?
|
| Dilatation, Pathologic | 1 | 2006 | 521 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2005 | 125 | 0.070 |
Why?
|
| P-Selectin | 1 | 2006 | 596 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 921 | 0.070 |
Why?
|
| Logistic Models | 2 | 2017 | 13647 | 0.070 |
Why?
|
| Adolescent | 6 | 2020 | 82796 | 0.070 |
Why?
|
| Adult | 10 | 2018 | 206295 | 0.070 |
Why?
|
| Young Adult | 5 | 2017 | 54078 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8471 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 716 | 0.070 |
Why?
|
| Patient Satisfaction | 3 | 2013 | 3331 | 0.070 |
Why?
|
| Child | 6 | 2020 | 68786 | 0.070 |
Why?
|
| Protein-Serine-Threonine Kinases | 1 | 2016 | 3918 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2006 | 13519 | 0.060 |
Why?
|
| Schools | 1 | 2011 | 1248 | 0.060 |
Why?
|
| Reoperation | 3 | 2021 | 4123 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 824 | 0.060 |
Why?
|
| Fat Necrosis | 2 | 2013 | 62 | 0.060 |
Why?
|
| Caspases | 1 | 2005 | 950 | 0.060 |
Why?
|
| Drug Implants | 2 | 2018 | 257 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2006 | 670 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2015 | 3797 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 1184 | 0.060 |
Why?
|
| Injury Severity Score | 2 | 2017 | 999 | 0.060 |
Why?
|
| Adipogenesis | 2 | 2014 | 327 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 3050 | 0.060 |
Why?
|
| Students | 1 | 2011 | 1479 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 940 | 0.060 |
Why?
|
| Neutropenia | 1 | 2005 | 831 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2005 | 1149 | 0.060 |
Why?
|
| Necrosis | 2 | 2018 | 1646 | 0.050 |
Why?
|
| Swine | 2 | 2021 | 5347 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 38875 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2007 | 3421 | 0.050 |
Why?
|
| Aged | 6 | 2021 | 156937 | 0.050 |
Why?
|
| Inflammation | 2 | 2018 | 9163 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2005 | 971 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2006 | 4407 | 0.050 |
Why?
|
| Registries | 1 | 2015 | 7622 | 0.050 |
Why?
|
| Middle Aged | 7 | 2018 | 210747 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2011 | 14748 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2021 | 793 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2021 | 297 | 0.050 |
Why?
|
| Ink | 1 | 2018 | 31 | 0.050 |
Why?
|
| Transfection | 2 | 2018 | 6367 | 0.050 |
Why?
|
| Antioxidants | 1 | 2006 | 1692 | 0.050 |
Why?
|
| Asthma | 1 | 2016 | 5541 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2018 | 458 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2018 | 37121 | 0.040 |
Why?
|
| Suction | 1 | 2018 | 253 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 2021 | 1479 | 0.040 |
Why?
|
| Sodium Salicylate | 1 | 2016 | 21 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2016 | 1719 | 0.040 |
Why?
|
| Tissue Expansion | 1 | 2018 | 162 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 28027 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2006 | 3212 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 9556 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 2018 | 189 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2018 | 281 | 0.040 |
Why?
|
| Anniversaries and Special Events | 1 | 2017 | 84 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 4196 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2016 | 5141 | 0.040 |
Why?
|
| Biliopancreatic Diversion | 1 | 2015 | 15 | 0.040 |
Why?
|
| Platelet-Rich Plasma | 1 | 2018 | 141 | 0.040 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2016 | 102 | 0.040 |
Why?
|
| Esthetics | 1 | 2017 | 296 | 0.040 |
Why?
|
| France | 1 | 2017 | 484 | 0.040 |
Why?
|
| Receptors, Steroid | 1 | 2016 | 149 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 2016 | 0.040 |
Why?
|
| Body Surface Area | 1 | 2015 | 225 | 0.040 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 107 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3085 | 0.040 |
Why?
|
| Immunosuppression | 1 | 2021 | 1544 | 0.040 |
Why?
|
| Program Development | 2 | 2013 | 1333 | 0.040 |
Why?
|
| Infant | 4 | 2020 | 33054 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2018 | 788 | 0.040 |
Why?
|
| Heart Failure | 1 | 2016 | 8606 | 0.040 |
Why?
|
| Needs Assessment | 2 | 2012 | 1160 | 0.040 |
Why?
|
| PAX7 Transcription Factor | 1 | 2014 | 54 | 0.040 |
Why?
|
| Protein Stability | 1 | 2016 | 542 | 0.040 |
Why?
|
| Time | 1 | 2016 | 528 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2016 | 279 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2016 | 232 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 470 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2016 | 372 | 0.030 |
Why?
|
| Stem Cell Transplantation | 2 | 2014 | 1635 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2014 | 2625 | 0.030 |
Why?
|
| Macrophages | 2 | 2006 | 5641 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2014 | 100 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 388 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2015 | 504 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 2074 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 343 | 0.030 |
Why?
|
| Hydrogels | 1 | 2018 | 581 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1815 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2016 | 1189 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 346 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 57680 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 1251 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9932 | 0.030 |
Why?
|
| Efficiency | 1 | 2016 | 455 | 0.030 |
Why?
|
| Cicatrix | 1 | 2018 | 636 | 0.030 |
Why?
|
| Neoplasms | 1 | 2020 | 18476 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 2713 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2014 | 6260 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 11584 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 1271 | 0.030 |
Why?
|
| Neutrophils | 1 | 2005 | 3753 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 2704 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1238 | 0.030 |
Why?
|
| Work Schedule Tolerance | 1 | 2016 | 528 | 0.030 |
Why?
|
| Patient Selection | 2 | 2017 | 4335 | 0.030 |
Why?
|
| Homozygote | 1 | 2016 | 1828 | 0.030 |
Why?
|
| Burns, Chemical | 1 | 2012 | 175 | 0.030 |
Why?
|
| Epigastric Arteries | 1 | 2010 | 70 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1755 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 66887 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 2487 | 0.030 |
Why?
|
| Hernia, Abdominal | 1 | 2010 | 56 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2017 | 63232 | 0.030 |
Why?
|
| Donor Selection | 1 | 2011 | 169 | 0.020 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 111 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2015 | 2647 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 1172 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1880 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Haiti | 1 | 2010 | 556 | 0.020 |
Why?
|
| Gene Expression | 2 | 2016 | 8071 | 0.020 |
Why?
|
| DNA Damage | 1 | 2018 | 2415 | 0.020 |
Why?
|
| Cell Separation | 1 | 2014 | 1885 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2006 | 21201 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1632 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2010 | 254 | 0.020 |
Why?
|
| Military Personnel | 1 | 2015 | 946 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 2132 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1922 | 0.020 |
Why?
|
| Incidence | 2 | 2017 | 19739 | 0.020 |
Why?
|
| Leptin | 1 | 2015 | 1581 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2017 | 22923 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 3113 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 23295 | 0.020 |
Why?
|
| Aorta | 2 | 2005 | 2124 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2016 | 15340 | 0.020 |
Why?
|
| Glucose | 1 | 2018 | 3931 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 6284 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2213 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 3671 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 936 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 848 | 0.020 |
Why?
|
| Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2005 | 55 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6563 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 148 | 0.020 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2009 | 622 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 492 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 2284 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 2499 | 0.020 |
Why?
|
| CHO Cells | 1 | 2007 | 1444 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2343 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2012 | 1798 | 0.020 |
Why?
|
| Device Removal | 1 | 2009 | 623 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 3031 | 0.020 |
Why?
|
| Skin | 1 | 2018 | 4362 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 6128 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 1001 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4107 | 0.020 |
Why?
|
| Drainage | 1 | 2009 | 1089 | 0.020 |
Why?
|
| Echocardiography | 1 | 2016 | 4958 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 2640 | 0.020 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 239 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2005 | 647 | 0.020 |
Why?
|
| Low Back Pain | 1 | 2010 | 796 | 0.020 |
Why?
|
| Physician's Role | 1 | 2010 | 1000 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3090 | 0.020 |
Why?
|
| Boston | 1 | 2016 | 9418 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2014 | 4261 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2007 | 721 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 4394 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 7026 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20102 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4677 | 0.010 |
Why?
|
| Length of Stay | 1 | 2015 | 6042 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 2953 | 0.010 |
Why?
|
| Protein Transport | 1 | 2007 | 2091 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3941 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 10147 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2011 | 1761 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 4935 | 0.010 |
Why?
|
| Sex Factors | 2 | 2005 | 10678 | 0.010 |
Why?
|
| Cell Communication | 1 | 2007 | 1617 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 15499 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 19040 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2011 | 1918 | 0.010 |
Why?
|
| Health Policy | 1 | 2011 | 2568 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 7782 | 0.010 |
Why?
|
| Estrogens | 1 | 2004 | 1473 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 5168 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 5751 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 24677 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 16504 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 9825 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 4773 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 11303 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 20390 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 46949 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 2833 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 27832 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15955 | 0.010 |
Why?
|